Increased Amount of Type III PN-collagen in Human Abdominal Aortic Aneurysms: Evidence for Impaired Type III Collagen Fibrillogenesis
Overview
General Surgery
Affiliations
Purpose: This study aimed to characterize the distribution of structural domains of type I and III collagens in the wall of abdominal aortic aneurysms (AAAs), by the use of undilated atherosclerotic aortas (aortoiliac occlusive disease [AOD]) and healthy abdominal aortas as controls.
Methods: Immunohistochemical staining was applied with antibodies for the aminoterminal propeptides of type I (PINP) and type III (PIIINP) procollagens, which represent newly synthesized type I and III pN-collagens. In addition, an antibody against the aminoterminal telopeptide of type III collagen (IIINTP) was used as a means of detecting maturely cross-linked type III collagen fibrils.
Results: The newly synthesized type III procollagen detected by means of PIIINP staining was concentrated in the media in aneurysmal aortas, whereas type I pN-collagen was localized in the intima in both AAAs and AODs. The healthy aortas showed no immunoreactivity for either PIIINP or PINP. The cross-linked type III collagen, detected by means of IIINTP staining, stained transmurally in all study groups, but appeared more abundant in the media in AAAs.
Conclusion: Our results strongly suggest that the metabolism of type III collagen is enhanced in AAAs. Intensive type III pN-collagen staining was present mainly in the media layer in AAAs, suggesting a role of type III collagen in aneurysm formation, whereas type I pN-collagen was present in the intima in both AAAs and AODs, suggesting that type I collagen synthesis is a fibroproliferative response related to the atherosclerotic process. The increased type III pN-collagen in AAAs may result in impaired fibril formation and, thus, in decreased tensile strength of aneurysmal tissue.
Exploring aortic stiffness in aging mice: a comprehensive methodological overview.
Vanalderwiert L, Henry A, de Souza E Silva J, Carvajal-Berrio D, Debelle L, Wahart A Aging (Albany NY). 2024; 17(2):280-307.
PMID: 39625407 PMC: 11892926. DOI: 10.18632/aging.206168.
de Freitas R, Dos Passos Jr R, Santos F, Bressan A, Carneiro F, Lima V J Mol Histol. 2024; 55(4):527-537.
PMID: 38898139 DOI: 10.1007/s10735-024-10202-8.
Angiotensin II Induces Aortic Rupture and Dissection in Osteoprotegerin-Deficient Mice.
Tsuruda T, Yamashita A, Otsu M, Koide M, Nakamichi Y, Sekita-Hatakeyama Y J Am Heart Assoc. 2022; 11(8):e025336.
PMID: 35411794 PMC: 9238451. DOI: 10.1161/JAHA.122.025336.
Wittig C, Szulcek R Front Physiol. 2021; 12:708656.
PMID: 34421650 PMC: 8371527. DOI: 10.3389/fphys.2021.708656.
Kopacz A, Kloska D, Werner E, Hajduk K, Grochot-Przeczek A, Jozkowicz A Cells. 2021; 10(1).
PMID: 33467682 PMC: 7830394. DOI: 10.3390/cells10010163.